143 related articles for article (PubMed ID: 27637965)
1. Neuroepidemiology of cancer and treatment-related neurocognitive dysfunction in adult-onset cancer patients and survivors.
Jean-Pierre P; McDonald BC
Handb Clin Neurol; 2016; 138():297-309. PubMed ID: 27637965
[TBL] [Abstract][Full Text] [Related]
2. Integrating functional near-infrared spectroscopy in the characterization, assessment, and monitoring of cancer and treatment-related neurocognitive dysfunction.
Jean-Pierre P
Neuroimage; 2014 Jan; 85 Pt 1():408-14. PubMed ID: 23831530
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development.
Jean-Pierre P; Johnson-Greene D; Burish TG
Support Care Cancer; 2014 Aug; 22(8):2251-60. PubMed ID: 24671433
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive dysfunction in survivors of childhood brain tumors.
Ullrich NJ; Embry L
Semin Pediatr Neurol; 2012 Mar; 19(1):35-42. PubMed ID: 22641074
[TBL] [Abstract][Full Text] [Related]
5. Either called "chemobrain" or "chemofog," the long-term chemotherapy-induced cognitive decline in cancer survivors is real.
Argyriou AA; Assimakopoulos K; Iconomou G; Giannakopoulou F; Kalofonos HP
J Pain Symptom Manage; 2011 Jan; 41(1):126-39. PubMed ID: 20832978
[TBL] [Abstract][Full Text] [Related]
6. Family Functioning Mediates the Association Between Neurocognitive Functioning and Health-Related Quality of Life in Young Adult Survivors of Childhood Brain Tumors.
Hocking MC; Hobbie WL; Deatrick JA; Hardie TL; Barakat LP
J Adolesc Young Adult Oncol; 2015 Mar; 4(1):18-25. PubMed ID: 25852971
[TBL] [Abstract][Full Text] [Related]
7. Coping with cancer-related cognitive dysfunction: a scoping review of the literature.
Sleight A
Disabil Rehabil; 2016; 38(4):400-8. PubMed ID: 25885669
[TBL] [Abstract][Full Text] [Related]
8. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response.
Boykoff N; Moieni M; Subramanian SK
J Cancer Surviv; 2009 Dec; 3(4):223-32. PubMed ID: 19760150
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma.
Edelmann MN; Daryani VM; Bishop MW; Liu W; Brinkman TM; Stewart CF; Mulrooney DA; Kimberg C; Ness KK; Cheung YT; Srivastava DK; Robison LL; Hudson MM; Krull KR
JAMA Oncol; 2016 Feb; 2(2):201-8. PubMed ID: 26583357
[TBL] [Abstract][Full Text] [Related]
10. Re: Neurocognitive functioning in adult survivors of childhood noncentral nervous system cancers.
Morelli AM; Ravera S; Panfoli I
J Natl Cancer Inst; 2011 Apr; 103(7):607; author reply 607-9. PubMed ID: 21350219
[No Abstract] [Full Text] [Related]
11. Cognitive dysfunction and cancer: which consequences in terms of disease management?
Joly F; Rigal O; Noal S; Giffard B
Psychooncology; 2011 Dec; 20(12):1251-8. PubMed ID: 21254307
[TBL] [Abstract][Full Text] [Related]
12. Clearing the air: a review of our current understanding of "chemo fog".
O'Farrell E; MacKenzie J; Collins B
Curr Oncol Rep; 2013 Jun; 15(3):260-9. PubMed ID: 23483375
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis.
Bernstein LJ; McCreath GA; Komeylian Z; Rich JB
Neurosci Biobehav Rev; 2017 Dec; 83():417-428. PubMed ID: 29092778
[TBL] [Abstract][Full Text] [Related]
14. Cognitive functions of adolescent childhood cancer survivors assessed by event-related potentials.
Lähteenmäki PM; Holopainen I; Krause CM; Helenius H; Salmi TT; Heikki LA
Med Pediatr Oncol; 2001 Apr; 36(4):442-50. PubMed ID: 11260567
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Neurocognitive Functioning and Social Attainment in Adult Survivors of Pediatric CNS Tumors: Results From the St Jude Lifetime Cohort Study.
Brinkman TM; Krasin MJ; Liu W; Armstrong GT; Ojha RP; Sadighi ZS; Gupta P; Kimberg C; Srivastava D; Merchant TE; Gajjar A; Robison LL; Hudson MM; Krull KR
J Clin Oncol; 2016 Apr; 34(12):1358-67. PubMed ID: 26834063
[TBL] [Abstract][Full Text] [Related]
17. Impact of perceived cognitive impairment in breast cancer survivors.
Von Ah D; Habermann B; Carpenter JS; Schneider BL
Eur J Oncol Nurs; 2013 Apr; 17(2):236-41. PubMed ID: 22901546
[TBL] [Abstract][Full Text] [Related]
18. A feasibility study of group cognitive rehabilitation for cancer survivors: enhancing cognitive function and quality of life.
Schuurs A; Green HJ
Psychooncology; 2013 May; 22(5):1043-9. PubMed ID: 22570263
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer and "chemobrain": the consequences of cognitive difficulties following chemotherapy and the potential for recovery.
Reid-Arndt SA
Mo Med; 2009; 106(2):127-31. PubMed ID: 19397112
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group.
Nathan PC; Patel SK; Dilley K; Goldsby R; Harvey J; Jacobsen C; Kadan-Lottick N; McKinley K; Millham AK; Moore I; Okcu MF; Woodman CL; Brouwers P; Armstrong FD;
Arch Pediatr Adolesc Med; 2007 Aug; 161(8):798-806. PubMed ID: 17679663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
